Globus Medical (GMED) Return on Capital Employed (2012 - 2026)

Globus Medical has reported Return on Capital Employed for 15 years, with the latest figure at 10.91% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 536.0% year-over-year to 10.91%; the trailing twelve-month figure through Mar 2026 stood at 10.91% (up 536.0% YoY), and the FY2025 full-year result was 10.04%, up 619.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 10.91%, up from 10.21% in the prior quarter.
• The five-year high for Return on Capital Employed was 12.23% in Q1 2023, with the low at 1.63% in Q2 2024.
• Historically, Return on Capital Employed has averaged 7.38% across 5 years, with a median of 8.13% in 2025.
• Annual changes were most pronounced in 2024 — Return on Capital Employed slumped 1023 bps — and 2025, when it soared 636 bps.
• Globus Medical's Return on Capital Employed stood at 12.21% in 2022, then sank by 77 bps to 2.76% in 2023, then surged by 40 bps to 3.85% in 2024, then surged by 165 bps to 10.21% in 2025, then gained by 7 bps to 10.91% in 2026.
• The last three Return on Capital Employed figures came in at 10.91% (Q1 2026), 10.21% (Q4 2025), and 8.13% (Q3 2025), per Business Quant data.